Table 2. Post-TAVI clinical laboratory data.
p-value <0.05 was considered statistically significant MMSE: Mini-Mental State Examination, SPPB: Short physical performance battery, CONUT: controlling nutritional status, Alb: albumin, BUN: blood urea nitrogen, CRE: creatinine, CRP: C-reactive protein, Hb: hemoglobin, BNP: brain natriuretic peptide, GFR: glomerular filtration rate, EF: ejection fraction, E/e': early filling, velocity/E wave with relaxation velocity on tissue doppler, E/A: early filling velocity / atrial filling velocity, AV peak V: aortic valve area velocity, AV mean PG: aortic valve mean pressure gradient, AVA: aortic valve area
| Delayed gait group (N=23) | Early gait group (N=46) | ||
| Mean±SD | p-value | ||
| MMSE (score) | 24.9 ± 3.8 | 25.7 ± 4.2 | 0.375 |
| 5m walk test(s) | 7.9 ± 3.2 | 6.3 ± 2.1 | 0.046 |
| 10m walk speed(m/s) | 0.8 ± 0.3 | 0.9 ± 0.3 | 0.045 |
| SPPB | 7.6 ± 2.5 | 9.2 ± 2.7 | 0.114 |
| Grip strength (kg) | 16.0 ± 7.5 | 18.8 ± 7.9 | 0.030 |
| Upper arm circumference (cm) | 24.5 ± 4.4 | 23.6 ± 4.1 | 0.347 |
| Lower Leg Circumference (cm) | 30.4 ± 4.1 | 29.5 ± 3.5 | 0.185 |
| CONUT (score) | 4.3 ± 2.5 | 3.9 ± 2.1 | 0.589 |
| Alb (g/dl) | 3.2 ± 0.6 | 3.4 ± 0.4 | 0.132 |
| BUN (mg/dl) | 23.2 ± 7.9 | 21.0 ± 8.5 | 0.135 |
| CRE (mg/dl) | 1.0 ± 0.4 | 0.9 ± 0.3 | 0.550 |
| CRP (mg/dl) | 1.6 ± 1.8 | 2.3 ± 5.0 | 0.990 |
| Hb (g/dl) | 10.9 ± 1.7 | 11.1 ± 1.6 | 0.302 |
| BNP (pg/ml) | 195.3 ± 307.1 | 118.6 ± 136.7 | 0.165 |
| GFR (ml/min/1.73m2) | 50.1 ± 19.0 | 54.5 ± 17.9 | 0.288 |
| EF (%) | 63.1 ± 14.7 | 63.1 ± 9.8 | 0.503 |
| E/e' | 27.5 ± 10.6 | 24.1 ± 10.2 | 0.161 |
| E/A | 1.0 ± 0.8 | 0.7 ± 0.2 | 0.181 |
| AV peak V (m/s) | 2.8 ± 3.1 | 2.4 ± 0.6 | 0.624 |
| AV mean PG (mmHg) | 10.8 ± 6.6 | 12.9 ± 7.2 | 0.276 |
| AVA (cm2) | 1.5 ± 0.5 | 1.7 ± 1.9 | 0.631 |